Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2699]
News [7554]
Articles [308]
Editorials [8]
Conferences [228]
elearning [48]
The importance of target expression in personalised medicine
Dr Paolo Nuciforo - Vall d'Hebron Institute of Oncology, Barcelona, Spain
The importance of target expression in personalised medicine ( Dr Paolo Nuciforo - Vall d'Hebron Institute of Oncology, Barcelona, Spain )
6 Jul 2015
SPECTAlung: improving clinical trial access for patients with thoracic tumours
Dr Jessica Menis and Dr Benjamin Besse
SPECTAlung: improving clinical trial access for patients with thoracic tumours ( Dr Jessica Menis and Dr Benjamin Besse )
3 Jul 2015
Biomarkers for childhood relapsed acute lymphoblastic leukaemia
Prof Anthony Moorman - Newcastle University, Newcastle, UK
Biomarkers for childhood relapsed acute lymphoblastic leukaemia ( Prof Anthony Moorman - Newcastle University, Newcastle, UK )
16 Jun 2015
Are CML patients being treated to the correct standard?
Dr Verena Hoffmann - Ludwig Maximilian University, Munich, Germany
Are CML patients being treated to the correct standard? ( Dr Verena Hoffmann - Ludwig Maximilian University, Munich, Germany )
16 Jun 2015
PDL1 expression in thymic tumours
Dr Giuseppe Giaccone - Georgetown University Medical Center, Washington, USA
PDL1 expression in thymic tumours ( Dr Giuseppe Giaccone - Georgetown University Medical Center, Washington, USA )
16 Jun 2015
Exciting update on the Repurposing Drugs in Oncology (ReDO) project
Dr Gauthier Bouche - Anticancer Fund, Strombeek-Bever, Belgium
Exciting update on the Repurposing Drugs in Oncology (ReDO) project ( Dr Gauthier Bouche - Anticancer Fund, Strombeek-Bever, Belgium )
15 Jun 2015
Overview of innovation in Hodgkin's lymphoma
Prof Volker Diehl - Winner of the Jean Bernard Lifetime Achievement Award
Overview of innovation in Hodgkin's lymphoma ( Prof Volker Diehl - Winner of the Jean Bernard Lifetime Achievement Award )
14 Jun 2015
Minimal residual disease in multiple myeloma
Dr Bruno Paiva - University Clinic of Navarra, Pamplona, Spain
Minimal residual disease in multiple myeloma ( Dr Bruno Paiva - University Clinic of Navarra, Pamplona, Spain )
14 Jun 2015
EHA 2015: Expert opinions on new treatment standard in multiple myeloma
Prof Pieter Sonneveld, Prof Antonio Palumbo, Prof Gordon McVie, Prof Thierry...
EHA 2015: Expert opinions on new treatment standard in multiple myeloma ( Prof Pieter Sonneveld, Prof Antonio Palumbo, Prof Gordon McVie, Prof Thierry Facon )
13 Jun 2015
Exploring "bad luck" - why do some patients develop myeloid leukaemia?
Dr George Vassiliou - Cambridge Cancer Centre, Cambridge, UK
Exploring "bad luck" - why do some patients develop myeloid leukaemia? ( Dr George Vassiliou - Cambridge Cancer Centre, Cambridge, UK )
13 Jun 2015
New definition for multiple myeloma improves patient outcomes
Prof Vincent Rajkumar - Mayo Clinic, Rochester, USA
New definition for multiple myeloma improves patient outcomes ( Prof Vincent Rajkumar - Mayo Clinic, Rochester, USA )
13 Jun 2015
Treatment and survival of patients with chronic myeloid leukaemia in Europe
Dr Verena Hoffmann - Ludwig-Maximilians-Universität, München, Germany
Treatment and survival of patients with chronic myeloid leukaemia in Europe ( Dr Verena Hoffmann - Ludwig-Maximilians-Universität, München, Germany )
12 Jun 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation